tiprankstipranks
Onconetix (ONCO)
NASDAQ:ONCO
Holding ONCO?
Track your performance easily

Onconetix (ONCO) Income Statement

127 Followers

Onconetix Income Statement

Last quarter (Q ), Onconetix's total revenue was $406.86K, an increase of Infinity% from the same quarter last year. In Q, Onconetix's net income was $-3.83M. See Onconetix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ -20.63M$ 58.47K-$ 0.00$ 0.00
Cost of Revenue
$ 2.60M$ 1.19M$ -500.00--
Gross Profit
$ -23.23M$ -1.13M$ 500.00--
Operating Expense
$ 48.66M$ 34.91M$ -13.48M$ 3.42M$ 1.62M
Operating Income
$ -49.39M$ -36.03M$ -13.48M$ -3.42M$ -1.62M
Net Non Operating Interest Income Expense
$ -723.07K$ -671.63K-$ 0.00$ 22.60K
Other Income Expense
$ 22.26M$ 18.77M$ -61.41K--
Pretax Income
$ -51.61M$ -37.29M$ -13.42M$ -3.42M$ -1.60M
Tax Provision
$ -139.39K$ -12.59K$ -3.16T--
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -51.60M$ -37.41M$ -13.52M$ -4.04M$ -2.16M
Basic EPS
$ -5.34$ -2.19$ -1.10$ -0.37$ -0.20
Diluted EPS
$ -5.34$ -2.19$ -1.10$ -0.37$ -0.20
Basic Average Shares
$ 64.76M$ 17.11M$ 12.27M$ 10.91M$ 11.05M
Diluted Average Shares
$ 64.76M$ 17.11M$ 12.27M$ 10.91M$ 11.05M
Dividend Per Share
--$ 1.23--
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 51.26M$ 36.09M$ -13.48M$ 3.42M$ 1.62M
Net Income From Continuing And Discontinued Operation
$ -51.60M$ -37.41M$ -13.42M$ -3.42M$ -1.60M
Normalized Income
$ -6.56M--$ -3.42M$ -1.60M
Interest Expense
-----
EBIT
$ -51.11M$ -36.62M$ -13.42M$ -3.42M$ -1.62M
EBITDA
$ -49.50M$ -35.90M$ -13.41M$ -3.41M$ -1.62M
Currency in USD

Onconetix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis